Improving diabetes patient outcomes in Indonesia
Helping patients managing their insulin treatment
Diabetes affects half a billion people around the globe. Its treatment greatly impacts the patient’s everyday life: patients must measure their glucose rates, self-administer insulin injections, adjust their lifestyles, and more. Indonesians face specific issues linked to the cultural characteristics of the country. Glucometers and needles are not always reimbursed, leading to low levels of use and increased risk of health-related issues.
The local diet consists mainly of rice-based meals particularly rich in sugar. In addition, preconceived ideas about insulin usage are common among the
Indonesian population.
In this context, our client, a global pharmaceutical leader in diabetes, needed to build an educational program for patients suffering from type 2 diabetes and treated with insulin that integrated the cultural specificities of the Indonesian population.
A hybrid personalized coaching program
In collaboration with the client, the Observia team co-created an integrated digital solution with a local call center to support diabetes patients under insulin treatments. We developed a highly personalized digital Patient Relationship Management (PRM) platform, powered by SPUR™, Observia’s behavioral diagnostic tool. This platform offers a digital coordination tool for nurses and integrates motivational scripts. Through personalized calls and short messages, each patient is supported individually and given access to quality content addressing any questions and fears about their treatment protocol. The platform also educates them on how to effectively initiate their insulin treatment.
- 4 months total
- 4 personalized calls from a nurse
- 3 to 7 personalized texts a week depending on the patient
Testimony
Figures
Results
Blood glucose levels are the main indicator of stabilization. Levels above 200 mg / L indicate the diabetes is not controlled and thus may negatively impact the patient’s life.
At the end of the program, the number of patients with uncontrolled diabetes is divided by 2.
+ 28 points of adherence
At the end of the program, 88% of patients adhered to their treatment, compared to 60% of the average population (local market research).
94,2% high satisfaction
The share of patients rating the program between 7 out of 10 or higher.
Conclusion
The program has proven to be effective, and our client has now conducted it for the fourth year in a row. Observia’s goal is now to maintain the quality of this program while facilitating the participation of new hospitals and patients.
See also
A multiple-cohort analysis of the SPUR 6/24 patient-reported adherence tool
Clinical Ink and Observia: Pioneering Personalized Patient Engagement in Clinical Trials
By your side in 2024: Happy Holidays from Observia!
Need more information?
A burning question, a specific request, a great project to share with us? Get in touch, our teams are here to help!
